States Sue Trump Administration Over Vaccine Rollback
Analysis based on 22 articles · First reported Feb 24, 2026 · Last updated Feb 25, 2026
The lawsuit against the Trump administration's vaccine policy could lead to increased spending for states to manage potential disease outbreaks, impacting state budgets. It also highlights ongoing political tensions that could affect public health sector investments and pharmaceutical companies involved in vaccine production.
More than a dozen states, including United States===Arizona and United States===California, have sued the Trump administration over its rollback of vaccine recommendations for children. The states argue that the United States===Centers for Disease Control and Prevention (CDC) jeopardized public health by ceasing to recommend universal immunization against diseases like flu, rotavirus, hepatitis A, hepatitis B, meningitis, and RSV. This new guidance, which suggests 'shared decision-making' or recommendations only for high-risk groups, has drawn criticism from medical experts and is seen as an illegal threat to public health. The lawsuit escalates an ongoing dispute between Democratic-led states and the Trump administration regarding federal public health policy, particularly under Health Secretary Robert F. Kennedy Jr. The complaint also alleges that Kennedy unlawfully ousted and replaced members of a vaccine advisory committee. This legal action follows an alliance formed by the governors of United States===California, United States===Washington (state), and United States===Oregon to establish their own vaccine guidelines, citing concerns about the politicization of the CDC.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard